Fonar Debt to Equity Ratio 2012-2025 | FONR
Current and historical debt to equity ratio values for Fonar (FONR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fonar debt/equity for the three months ending September 30, 2025 was 0.00.
| Fonar Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.06B | $0.16B | 0.35 |
| 2025-06-30 | $0.06B | $0.16B | 0.36 |
| 2025-03-31 | $0.06B | $0.16B | 0.34 |
| 2024-12-31 | $0.05B | $0.16B | 0.31 |
| 2024-09-30 | $0.05B | $0.16B | 0.34 |
| 2024-06-30 | $0.06B | $0.16B | 0.37 |
| 2024-03-31 | $0.05B | $0.16B | 0.34 |
| 2023-12-31 | $0.05B | $0.16B | 0.29 |
| 2023-09-30 | $0.05B | $0.15B | 0.31 |
| 2023-06-30 | $0.05B | $0.15B | 0.33 |
| 2023-03-31 | $0.05B | $0.15B | 0.32 |
| 2022-12-31 | $0.05B | $0.15B | 0.33 |
| 2022-09-30 | $0.05B | $0.15B | 0.35 |
| 2022-06-30 | $0.05B | $0.15B | 0.36 |
| 2022-03-31 | $0.05B | $0.14B | 0.36 |
| 2021-12-31 | $0.05B | $0.14B | 0.36 |
| 2021-09-30 | $0.05B | $0.14B | 0.35 |
| 2021-06-30 | $0.05B | $0.14B | 0.40 |
| 2021-03-31 | $0.05B | $0.14B | 0.37 |
| 2020-12-31 | $0.05B | $0.13B | 0.38 |
| 2020-09-30 | $0.05B | $0.13B | 0.42 |
| 2020-06-30 | $0.05B | $0.13B | 0.43 |
| 2020-03-31 | $0.05B | $0.13B | 0.36 |
| 2019-12-31 | $0.05B | $0.13B | 0.37 |
| 2019-09-30 | $0.04B | $0.12B | 0.36 |
| 2019-06-30 | $0.02B | $0.12B | 0.13 |
| 2019-03-31 | $0.01B | $0.11B | 0.11 |
| 2018-12-31 | $0.01B | $0.11B | 0.12 |
| 2018-09-30 | $0.01B | $0.11B | 0.12 |
| 2018-06-30 | $0.02B | $0.10B | 0.16 |
| 2018-03-31 | $0.01B | $0.09B | 0.15 |
| 2017-12-31 | $0.02B | $0.09B | 0.17 |
| 2017-09-30 | $0.02B | $0.09B | 0.18 |
| 2017-06-30 | $0.02B | $0.08B | 0.19 |
| 2017-03-31 | $0.02B | $0.08B | 0.22 |
| 2016-12-31 | $0.02B | $0.07B | 0.28 |
| 2016-09-30 | $0.02B | $0.07B | 0.31 |
| 2016-06-30 | $0.02B | $0.06B | 0.40 |
| 2016-03-31 | $0.02B | $0.06B | 0.41 |
| 2015-12-31 | $0.03B | $0.06B | 0.45 |
| 2015-09-30 | $0.03B | $0.05B | 0.49 |
| 2015-06-30 | $0.03B | $0.05B | 0.51 |
| 2015-03-31 | $0.03B | $0.05B | 0.59 |
| 2014-12-31 | $0.03B | $0.05B | 0.57 |
| 2014-09-30 | $0.03B | $0.05B | 0.64 |
| 2014-06-30 | $0.03B | $0.05B | 0.67 |
| 2014-03-31 | $0.03B | $0.04B | 0.75 |
| 2013-12-31 | $0.04B | $0.04B | 0.83 |
| 2013-09-30 | $0.04B | $0.04B | 0.88 |
| 2013-06-30 | $0.04B | $0.04B | 0.94 |
| 2013-03-31 | $0.04B | $0.04B | 1.10 |
| 2012-12-31 | $0.02B | $0.01B | 1.60 |
| 2012-09-30 | $0.02B | $0.01B | 1.81 |
| 2012-06-30 | $0.02B | $0.01B | 2.03 |
| 2012-03-31 | $0.02B | $0.01B | 2.27 |
| 2011-12-31 | $0.02B | $0.01B | 2.65 |
| 2011-09-30 | $0.03B | $0.01B | 3.44 |
| 2011-06-30 | $0.03B | $0.01B | 4.38 |
| 2011-03-31 | $0.03B | $0.00B | -34.74 |
| 2010-12-31 | $0.03B | $0.00B | -7.77 |
| 2010-09-30 | $0.03B | $-0.01B | -5.23 |
| 2010-06-30 | $0.03B | $-0.01B | -4.75 |
| 2010-03-31 | $0.03B | $-0.01B | -5.00 |
| 2009-12-31 | $0.03B | $-0.01B | -5.24 |
| 2009-09-30 | $0.03B | $-0.01B | -6.90 |
| 2009-06-30 | $0.03B | $0.00B | -10.64 |
| 2009-03-31 | $0.03B | $0.00B | -10.84 |
| 2008-12-31 | $0.04B | $0.00B | -9.80 |
| 2008-09-30 | $0.04B | $-0.01B | -8.20 |
| 2008-06-30 | $0.04B | $0.00B | -9.30 |
| 2008-03-31 | $0.04B | $0.00B | 15.33 |
| 2007-12-31 | $0.04B | $0.01B | 6.95 |
| 2007-09-30 | $0.03B | $0.01B | 3.78 |
| 2007-06-30 | $0.03B | $0.01B | 3.63 |
| 2007-03-31 | $0.03B | $0.02B | 1.79 |
| 2006-12-31 | $0.03B | $0.02B | 1.34 |
| 2006-09-30 | $0.03B | $0.03B | 0.93 |
| 2006-06-30 | $0.03B | $0.03B | 0.88 |
| 2006-03-31 | $0.02B | $0.04B | 0.63 |
| 2005-12-31 | $0.03B | $0.04B | 0.56 |
| 2005-09-30 | $0.02B | $0.05B | 0.47 |
| 2005-06-30 | $0.02B | $0.05B | 0.47 |
| 2005-03-31 | $0.02B | $0.05B | 0.46 |
| 2004-12-31 | $0.03B | $0.05B | 0.62 |
| 2004-09-30 | $0.03B | $0.05B | 0.73 |
| 2004-06-30 | $0.03B | $0.04B | 0.79 |
| 2004-03-31 | $0.03B | $0.04B | 0.85 |
| 2003-12-31 | $0.03B | $0.04B | 0.69 |
| 2003-09-30 | $0.03B | $0.03B | 0.76 |
| 2003-06-30 | $0.03B | $0.03B | 0.81 |
| 2003-03-31 | $0.03B | $0.03B | 1.07 |
| 2002-12-31 | $0.03B | $0.03B | 0.99 |
| 2002-09-30 | $0.04B | $0.04B | 1.01 |
| 2002-06-30 | $0.04B | $0.04B | 1.05 |
| 2002-03-31 | $0.04B | $0.04B | 0.91 |
| 2001-12-31 | $0.04B | $0.04B | 1.01 |
| 2001-09-30 | $0.04B | $0.04B | 1.01 |
| 2001-06-30 | $0.04B | $0.04B | 1.03 |
| 2001-03-31 | $0.04B | $0.05B | 0.80 |
| 2000-12-31 | $0.00B | 0.00 | |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.00B | 0.00 | |
| 1998-12-31 | $0.04B | $0.07B | 0.59 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1998-03-31 | $0.00B | 0.00 | |
| 1996-09-30 | $0.00B | 0.00 | |
| 1996-06-30 | $0.00B | 0.00 | |
| 1996-03-31 | $0.00B | 0.00 | |
| 1995-12-31 | $0.00B | 0.00 | |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-03-31 | $0.00B | 0.00 | |
| 1994-12-31 | $0.00B | 0.00 | |
| 1994-09-30 | $0.00B | 0.00 | |
| 1994-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.116B | $0.104B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Verano Holdings (VRNO) | United States | $0.450B | 0.00 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.198B | 17.75 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |